Real-time enrollment status for this central line infections clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06822426 |
| Recruiting Status | Recruiting |
| Condition | Central Line Infections |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 11 sites in the US |
| Sponsor | CorMedix |
| Last Updated on CT.gov | December 24, 2025 (Dec 24, 2025) |
As of March 2, 2026: Clinical trial NCT06822426 is currently recruiting participants. This clinical trial study for central line infections is actively seeking new participants at 11 locations across the United States. The study is sponsored by CorMedix. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06822426 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06822426 was last updated Dec 24, 2025 (December 24, 2025). HelloStudys verifies this status automatically.